Transforming Health Security


Accelerate the development and availability of transformative technologies and approaches to protect Americans from health security threats.

Our Strategy

Push the boundaries of innovation to tackle the biggest health security challenges.

Seek new ideas and new approaches to find solutions that will prevent and protect against health security threats.

Situational Awareness/Recognize: How do we know something is happening, an agent has entered the community. Identification/Characterize: What is it, is it drug resistant, are certain subpopulations more susceptible, will it become an epidemic? Design: How do we stop the spread fo the disease? Drugs, vaccines, PPE, social distancing? Validate: Methods under design are evaluated, clinical trials, non-clinical trials, epidemiology, surveillance. Produce: On demand manufacturing of X. Distribute: Novel ways to get product/information to htose who need it. Administration: Everyone who needs X is provided X.

The DRIVe Business Model

DRIVe is forming unique public private partnerships. DRIVe will leverage new authorities given to BARDA under the 21st Century Cures Act to stimulate innovation through both non-dilutive funding and dilutive funding. In addition, through our DRIVe Accelerator Network, we will have teams forward deployed throughout the USA to identify promising solutions wherever innovation is happening. Together we are building out an ecosystem of restless innovation, driven by industry and the entrepreneurial community, to address our nation's largest health security threats.

More information on partnering


BARDA is responsible for developing and procuring technologies and countermeasures to protect the nation against natural and man-made threats. We have delivered solutions to protect our country and the world from threats like Anthrax, Smallpox, Ebola, Pandemic Influenza, and many others. Since it was established in 2006, as part of the Pandemic and All Hazards Preparedness Act, BARDA has facilitated 35 FDA approvals, licensures, and clearances for products addressing a wide range of chemical, biological, radiological, and nuclear threats; pandemic influenza; and emerging infectious diseases. BARDA's mission is accomplished through successful public-private partnerships with industry to share risk, improve efficiency, and accelerate development all while sustaining a marketplace that guarantees continued access to the vaccines, therapeutics, diagnostics, and other medical products that are vital to our national health security.

Contact or Follow us

This site will be updated regularly, but you can also contact DRIVe by email at

Or follow us on Twitter:

And sign up for DRIVe email updates.